Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Lagevrio
Posted inCOVID-19, Infections, New Drugs, Regulatory
Molnupiravir Approved in the U.S.
An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.
Posted inClinical Trials, COVID-19, Infections
Molnupiravir: New Effective Pill for Coronavirus. All That We Know
Molnupiravir pills by Merck & Co. can help COVID-19 patients avoid going to the hospital or dying.
Posted inCOVID-19, Infections, Regulatory
Molnupiravir: What U.S. Experts Said
FDA scientists took a detailed look at molnupiravir for treating COVID-19.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Lagevrio: New Antiviral Drug to Treat COVID-19
The oral antiviral drug molnupiravir by Merck & Co.
